CorMedix names Elizabeth Hurlburt chief operating and commercial officer
Share
Listen to the news
CorMedix names Elizabeth Hurlburt chief operating and commercial officer
  • CorMedix reshaped its executive structure on June 29, 2026, naming COO Elizabeth Hurlburt to a new Chief Operating and Commercial Officer role.
  • Hurlburt adds oversight of commercial functions to her remit, alongside medical affairs, regulatory, and clinical responsibilities.
  • She will continue reporting to Chairman and CEO Joseph Todisco.
  • Michael Seckler departed the company as part of the leadership change.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CorMedix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001410098-26-000040), on July 02, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending